论文部分内容阅读
目的探讨治疗肾性高血压有效方法。方法选取我院2010年11月-2011年11月间入院治疗的96例肾性高血压患者为研究对象,按照治疗方法的不同分成厄贝沙坦组、依那普利组和联用组,每组32例患者。对患者治疗前后的相关资料进行了比较分析。结果厄贝沙坦组、依那普利组在收缩压和舒张压方面与联用组比较,P均>0.05,差异无统计学意义;在尿蛋白方面厄贝沙坦组、依那普利组与联用组比较,P均<0.05,差异具有统计学意义。结论厄贝沙坦与依那普利联用治疗肾性高血压的临床效果较好,是一种治疗肾性高血压的有效和安全的方法。
Objective To explore effective methods of treating renal hypertension. Methods Ninety-six patients with renal hypertension who were admitted to our hospital from November 2010 to November 2011 were selected as the research object and divided into irbesartan group, enalapril group and combination group according to different treatment methods. 32 patients in each group. Before and after treatment of patients with relevant data were analyzed. Results Irbesartan group and enalapril group systolic blood pressure and diastolic blood pressure in the combined group, P> 0.05, the difference was not statistically significant; urinary protein in the irbesartan group, enalapril Compared with the combined group, P <0.05, the difference was statistically significant. Conclusion The combination of irbesartan and enalapril is effective in treating renal hypertension and is an effective and safe method for the treatment of renal hypertension.